πŸ‡ΊπŸ‡Έ FDA
Patent

US 8586711

Polymer-factor IX moiety conjugates

granted A61KA61K38/4846A61K47/60

Quick answer

US patent 8586711 (Polymer-factor IX moiety conjugates) held by Nektar Therapeutics expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/4846, A61K47/60, A61P, A61P7/04